`Seeing through a glass darkly': casting light on imidazoline `I' sites
- 1 September 1998
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 19 (9), 381-390
- https://doi.org/10.1016/s0165-6147(98)01244-9
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbitsNeurochemistry International, 1997
- Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and BNeurochemistry International, 1997
- An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritisNeuroReport, 1996
- Decreased Number and Immunoreactivity of I2‐Imidazoline Receptors in the Frontal Cortex of Suicide Victimsfn1Annals of the New York Academy of Sciences, 1995
- Identifying Clonidine-Displacing SubstanceScience, 1994
- Agmatine: an Endogenous Clonidine-Displacing Substance in the BrainScience, 1994
- Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cellsDiabetes, 1993
- Reduction in Focal Cerebral Ischemia by Agents Acting at Imidazole ReceptorsJournal of Cerebral Blood Flow & Metabolism, 1992
- An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medullaLife Sciences, 1986
- An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferensBiochemical and Biophysical Research Communications, 1986